This month we launched J&J Satellite Center for Global Health Discovery at the London School of Hygiene & Tropical Medicine.
This first-of-its-kind Center is an important step to stimulate and speed up early-stage R&D for entrenched and emerging pandemic threats that disproportionately impact the world’s poorest and most vulnerable people.
EADAM named Awardee in Black Innovators in Skin Health QuickFire Challenge
Johnson & Johnson Innovation, together with Neutrogena®, recently announced that EADEM has been selected as the awardee in Black Innovators in Skin Health QuickFire Challenge. The challenge offered an opportunity for U.S.-based Black innovators working on potential skin and scalp health solutions to receive grant funding and mentorship.
The Future of Immunodermatology Treatment: A Conversation with Janssen Immunology’s Lloyd Miller
Lloyd Miller, M.D., Ph.D., Vice President, Immunodermatology Disease Area Leader at Janssen Immunology, spoke with Jason Witherington, Vice President of Immunology Scientific Innovation at Janssen about his career journey as a clinician-scientist and why he is optimistic about the next generation of potentially transformational therapies for patients living with immune-mediated skin conditions.